<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04457882</url>
  </required_header>
  <id_info>
    <org_study_id>PD2020-001</org_study_id>
    <nct_id>NCT04457882</nct_id>
  </id_info>
  <brief_title>Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube</brief_title>
  <official_title>Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube: a Singlecentre, Randomised Controlled, and Non-inferiority Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai East Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai East Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled and non-inferiority trial in comparison of intraperitoneal
      laparoscopic radical prostatectomy without drainage tube between intraperitoneal laparoscopic
      radical prostatectomy with drainage tube in the safety in men with a loacalized prostate
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is a prospective, single-centre, randomized controlled, and non-inferiority study
      in which all men with localized prostate cancer. This study aims to determine whether
      intraperitoneal laparoscopic radical prostatectomy without drainage tube is non-inferior to
      intraperitoneal laparoscopic radical prostatectomy with drainage tube in the safety in men
      with a loacalized prostate cancer.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The rate of adverse event</measure>
    <time_frame>3 month</time_frame>
    <description>Any adverse event according to the Clavien-Dindo classification will be recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>3 Months</time_frame>
    <description>The difference between postoperative hemoglobin and preoperative hemoglobin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical recovery</measure>
    <time_frame>3 Months</time_frame>
    <description>The first time to go to the ground after the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal function recovery</measure>
    <time_frame>3 Months</time_frame>
    <description>The first time to eat after the operation, the first time to exit gas after the operation,the first time to cacation after the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal effusion and cyst</measure>
    <time_frame>3 Months</time_frame>
    <description>The ultrasound and CT to detect if there is abdominal effusion and cyst</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Without Drainage Tube</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No place the drainage tube after the intraperitoneal laparoscopic radical prostatectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>With Drainage Tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Place the drainage tube after the intraperitoneal laparoscopic radical prostatectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intraperitoneal Laparoscopic Radical Prostatectomy Without Drainage Tube</intervention_name>
    <description>No place the drainage tube after the intraperitoneal Laparoscopic Radical Prostatectomy</description>
    <arm_group_label>Without Drainage Tube</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intraperitoneal Laparoscopic Radical Prostatectomy With Drainage Tube</intervention_name>
    <description>Place the drainage tube after the intraperitoneal Laparoscopic Radical Prostatectomy</description>
    <arm_group_label>With Drainage Tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age: more than 18 years old, less than 85 years old;

          2. Patient who pathologically diagnosed with prostate cancer and plan to undergo radical
             laparoscopic surgery for prostate cancer;

          3. fully understand the clinical trial protocol and sign the informed consent;

        Exclusion Criteria:

          1. patients with surgical contraindications who cannot accept surgery;

          2. patients with non-laparoscopic radical resection of prostate cancer;

          3. patients with previous pelvic radiation therapy and complicated abdominal surgery;

          4. patients judged by the investigator to be unsuitable to participate in the clinical
             trial;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haifeng Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai East Hospital,Tongji University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Biming He</last_name>
    <phone>+8615502139410</phone>
    <email>190589109@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haifeng Wang</last_name>
    <phone>+8613681750891</phone>
    <email>446720864@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai East Hospital, Tongji University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 1, 2020</study_first_submitted>
  <study_first_submitted_qc>July 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2020</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate Cancer</keyword>
  <keyword>Laparoscopic Radical Prostatectomy</keyword>
  <keyword>Intraperitoneal</keyword>
  <keyword>Drainage Tube</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

